Results 11 to 20 of about 10,318 (215)

Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI [PDF]

open access: yesIranian Journal of Reproductive Medicine, 2011
Background: Polycystic ovary syndrome (PCOS) is associated with approximately 75% of women who suffer from infertility due to anovulation. Additionally, around 20– 25% of anovulatory women with PCOS do not respond at all to clomiphene citrate and are ...
Mohammad Hossein Fallahzadeh   +2 more
doaj   +1 more source

Comparison Between Two Methods of Ovulation Induction: Clomiphene Alone and Clomiphene +Tamoxifen in PCOS Patients [PDF]

open access: yesDiyala Journal of Medicine, 2019
Background: Infertility affects about 10-15% of reproductive-age couples. About half the causes of infertility are female related and approximately 40% of the cases are caused by anovulation, mostly in PCO women.
Ali Hassan Mohammed
doaj   +3 more sources

Clomiphene-Metformin vs Clomiphene in Infertil Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis

open access: yesObgynia
Objective: To compare the efficacy of clomiphene citrate and metformin with clomiphene citrate alone in treating primary infertility in women with polycystic ovarian syndrome.
Arifah Mabruroh Prilia   +3 more
doaj   +6 more sources

Clomiphene based ovarian stimulation in a commercial donor program

open access: yesJournal of Human Reproductive Sciences, 2015
OBJECTIVE: This study was conducted to compare an extended clomiphene-based ovarian stimulation regimen with the conventional antagonist protocol in donor-recipient cycles.
Shruti Gupta   +4 more
doaj   +2 more sources

Effect of oral Tadalafil on endometrial thickness in patients receiving Clomiphene citrate for ovulation induction

open access: yesMiddle East Fertility Society Journal, 2018
Background: Adequate and optimum endometrial development is required for a successful pregnancy to occur. Clomiphene citrate is well known for its negative impact on endometrial thickness.
Islam Mohamed Magdi Ammar   +1 more
doaj   +2 more sources

Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate - resistant polycystic ovarian syndrome patients [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2016
Introduction. Polycystic ovary syndrome is the most common endocrinopathy in women of reproductiveage. Therapy for those who want to get pregnant involves ovulation induction using clomiphene citrate, metformin, letrozole and gonadotropins ...
Bjelica Artur   +4 more
doaj   +2 more sources

Compared Antileishmanial Activity of Clomiphene and Tamoxifen

open access: yesBiomedicines
Drug repositioning is an efficient strategy to search for new treatment alternatives that is especially valuable for neglected parasitic diseases such as leishmaniasis. Tamoxifen and raloxifene are selective estrogen receptor modulators (SERMs) that have
Sergio Sifontes-Rodríguez   +10 more
doaj   +2 more sources

Menometrorrhagia of the puberty: therapy with Clomiphene (Clomiphene and puberal menometrorrhagia).

open access: yesActa Europaea fertilitatis, 1977
The authors administrated the Clomiphene, in different doses, to 8 patients among 27 observed. These patients were checked for a long time by basal body temperature and in some cases, measuring total urinary estrogens and pregnandioluria. The therapy was administrated in 38 cicles of the 163 cicles observed.
Garcea, Nicola   +4 more
openaire   +3 more sources

Melanoma Cells Exposed to Clomiphene Citrate Respond With Cell Cycle Arrest and Reduced Invasiveness. [PDF]

open access: yesJ Appl Toxicol
ABSTRACT Epidemiological studies have suggested that clomiphene citrate (CC) exposure may increase the risk of malignant melanoma, but mechanisms are unknown. We investigated the effects of CC on melanoma cell line A375. Cells were treated with CC at 2, 20, 200, and 2000 ng/mL, followed by assessment of cell viability and metabolism, cell cycle ...
Ribeiro TS   +8 more
europepmc   +2 more sources

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. [PDF]

open access: yes, 2009
To assess long-term health effects of ovarian-stimulation drugs we followed-up for over 20 years a British cohort of 7355 women with ovulatory disorders, 43% of whom were prescribed ovarian-stimulation drugs, and identified a total of 274 deaths and 367 ...
Overton, C   +30 more
core   +1 more source

Home - About - Disclaimer - Privacy